1. Home
  2. ELVN vs ACEL Comparison

ELVN vs ACEL Comparison

Compare ELVN & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • ACEL
  • Stock Information
  • Founded
  • ELVN 2016
  • ACEL 2009
  • Country
  • ELVN United States
  • ACEL United States
  • Employees
  • ELVN N/A
  • ACEL N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • ACEL Services-Misc. Amusement & Recreation
  • Sector
  • ELVN Health Care
  • ACEL Consumer Discretionary
  • Exchange
  • ELVN Nasdaq
  • ACEL Nasdaq
  • Market Cap
  • ELVN 927.8M
  • ACEL 952.2M
  • IPO Year
  • ELVN 2020
  • ACEL N/A
  • Fundamental
  • Price
  • ELVN $21.30
  • ACEL $11.28
  • Analyst Decision
  • ELVN Strong Buy
  • ACEL Buy
  • Analyst Count
  • ELVN 5
  • ACEL 1
  • Target Price
  • ELVN $39.60
  • ACEL $16.00
  • AVG Volume (30 Days)
  • ELVN 594.3K
  • ACEL 241.6K
  • Earning Date
  • ELVN 08-12-2025
  • ACEL 07-29-2025
  • Dividend Yield
  • ELVN N/A
  • ACEL N/A
  • EPS Growth
  • ELVN N/A
  • ACEL N/A
  • EPS
  • ELVN N/A
  • ACEL 0.49
  • Revenue
  • ELVN N/A
  • ACEL $1,253,067,000.00
  • Revenue This Year
  • ELVN N/A
  • ACEL $9.02
  • Revenue Next Year
  • ELVN N/A
  • ACEL $4.84
  • P/E Ratio
  • ELVN N/A
  • ACEL $22.90
  • Revenue Growth
  • ELVN N/A
  • ACEL 6.28
  • 52 Week Low
  • ELVN $13.30
  • ACEL $9.02
  • 52 Week High
  • ELVN $30.03
  • ACEL $12.96
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 55.53
  • ACEL 49.50
  • Support Level
  • ELVN $18.53
  • ACEL $11.01
  • Resistance Level
  • ELVN $24.11
  • ACEL $11.77
  • Average True Range (ATR)
  • ELVN 1.96
  • ACEL 0.22
  • MACD
  • ELVN 0.15
  • ACEL -0.03
  • Stochastic Oscillator
  • ELVN 55.68
  • ACEL 36.29

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About ACEL Accel Entertainment Inc.

Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.

Share on Social Networks: